JOURNEY to 50c plus, page-317

Talk about potential upside and downside. Talk about the credibility of pulling this trial off or not. Talk about the nature of
implied as well as explicit management guidance. Nothing new there. But for me, I felt a decided difference in the tone
of the recent AGM Q & A session. Less hype, more understated and substantiated confidence. Clear wariness where due.

When the Co finishes the current trial the SP will rise enough to give even the captive vocal holders who don't want to be
holders an exit route...but, we need to meet the ambitious target of 10-12 or 15 patients tested first. The Co has made it clear that
incentivising patients is not an option currently as it's the 'Principal Investigator' who has the final say in this matter and
so far, and I stress so far, the 'Principal Investigator has said that they have ethical issues with it.

The hype was absent and the caveats were continuous, I've also spoken to the Co since then...but I got the sense that they are confident
in the traction that will come with the significantly increased number of breast cancer patients now being screened. I definitely get the sense
that we have much, much more than just a faint pulse.

So all in all...a good AGM recording. I appreciated Geoff's efforts in asking all the questions put forward by holders. Those who haven't
listened to it may find it a valuable investment of 23 minutes of their life. I'm bitterly disappointed in where we are, but more (cautiously)
optimistic about the next 3-6 months. But it sounds like the next 1-3 months are the key to whether that slightly longer journey will be
endured (by some). Let us see.